MTEM Molecular Templates
- 1.5500
- -0.0500-3.13%
Molecular Templates News
Express News | Molecular Templates Inc Files For Shelf Of Up To 11.01M Shares Of Common Stock By Selling Stockholders
Express News | Molecular Templates Inc Files for Shelf of up to 11.01 Mln Shares of Common Stock by Selling Stockholders - SEC Filing
Molecular Templates to Cut 30% of Staff, Chief Medical Officer
By Ben Glickman Molecular Templates said it would lay off about 30% of its workforce and cut its chief medical officer as it looks to stretch its resources. The Austin, Texas-based biopharmaceutical
Express News | Molecular Templates Inc Estimates That It Will Incur Aggregate Pre-Tax Charges Of ~$0.1M In Connection With Reduction In Force; Effective April 30; Reduction To Extend Resources To Allow Co To Continue To Support Clinical Studies For MT-6402, MT-8421 And
Express News | Molecular Templates Inc Says Reduction In Force Would Reduce Company's Current Workforce By ~30%; Approved A Reduction In Force; Expects That Reduction In Force Will Be Complete By End Of April 2024
Express News | Molecular Templates: Reduction to Extend Resources to Allow Co to Continue to Support Clinical Studies for Mt-6402, Mt-8421 and Mt-0169
Express News | Molecular Templates Inc - Effective April 30, & in Connection With Reduction in Force, Maurizio Voi, Will Cease to Serve as Chief Medical Officer
Express News | Molecular Templates Inc - Estimates That It Will Incur Aggregate Pre-Tax Charges of Approximately $0.1 Mln in Connection With Reduction in Force
Express News | Molecular Templates Inc: Expects That Reduction in Force Will Be Complete by End of April 2024
Express News | Molecular Templates Inc - Approved a Reduction in Force
Express News | Molecular Templates Inc: Reduction in Force Would Reduce Company's Current Workforce by Approximately 30%
Molecular Templates, Inc. (NASDAQ:MTEM) Looks Inexpensive After Falling 47% But Perhaps Not Attractive Enough
The Molecular Templates, Inc. (NASDAQ:MTEM) share price has fared very poorly over the last month, falling by a substantial 47%. For any long-term shareholders, the last month ends a year to forget
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersJaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. aTyr Pharma (NASDAQ:LIFE) shares rose 10.45% to $
What's Going On With Molecular Templates Stock?
Molecular Templates, Inc (NASDAQ:MTEM) shares are volatile Tuesday after the company presented interim data from MT-6402 Phase I study in patients with PD-L1+ solid tumors. The Details:Molecular Templ
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals Among Healthcare Movers
Express News | Molecular Templates Shares Are Trading Higher After the Company Announced That It Will Present Interim Data From Its MT-6402 Phase I Study in Patients With PD-L1+ Solid Tumors at the 2024 AACR Annual Meeting
Molecular Templates Presents Interim Data From MT-6402 Phase I Study In Patients With PD-L1+ Solid Tumors At 2024 AACR Annual Meeting
The poster highlighted the following findings from the phase I dose-escalation study of MT-6402:MT-6402 has been well tolerated with no drug-related Grade 4 or Grade 5 adverse events observedMT-6402 a
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersProtara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday's pre-market session. The market value of their outstanding shares is at $64.4 million. Candel Therapeutics (N
Molecular Templates 4Q Research and Development Expenses $8.8M >MTEM
Molecular Templates 4Q Research and Development Expenses $8.8M >MTEM
Molecular Templates 4Q EPS 73c >MTEM
Molecular Templates 4Q EPS 73c >MTEM
Analysis
Price Target
No Data
